We fund projects that directly impact the replacement of animals in biomedical research.Â
Animal Free Research UK provides several types of grant funding:
Pilot Grants: Fully animal-free projects which don’t use any animal-derived products (ADPs), cell culture reagents or antibodies.
Transition Grants: Projects with a clear plan to replace animal-derived products in all or part of the methods. Researchers may carry out side-by-side comparison studies to study the differences between animal- and non-animal products, validating animal-free methods for use in future work. However, Animal Free Research UK funds must not be used to purchase any animal-derived products for use in the project.
ARC Grants: Rolling grants to support our Animal Replacement Centres of Excellence (ARCs).
What are animal-derived products (ADPs)?
Animal-derived products (ADPs) are used widely in research. They are often by-products of the meat and dairy industries, raising both ethical and scientific concerns.
Some key examples include:
- Foetal calf serum (FCS), also known as foetal bovine serum (FBS): This product is extracted from the hearts of unborn calves after slaughter of a pregnant cow. It is used in almost every laboratory worldwide as a cell growth supplement, despite being an animal-derived product that has compatability issues when used with human cells. FCS also raises other well-known scientific problems, including batch-to-batch variation and the risk of contamination or infection, both of which can make experimental results unreliable and difficult to reproduce. Although animal-free alternatives are now available, global demand for FCS remains high, resulting in that an estimated 1-3 million calves being used in its production every year, raising a major ethical issue.
- Animal-derived antibodies: Millions of animals are used every year in the production of antibodies around the world. Animals are immunised to stimulate antibody production, and their blood is then drawn, often repeatedly, to harvest the antibodies for research use. These products are not only expensive but also inconsistent, as each batch is made in a different animal. To support researchers in making more ethical and reproducible choices, our Recombinant Antibodies & Mimetics Database provides detailed, transparent information on animal-free antibody alternatives and the methods used to produce them.
- Matrices, scaffolds and hydrogels: These gel-like supports are used to help cells to grow in 3D when forming spheroids or organoids. Many of these products are made using animal-derived components such as collagen or gelatin, while others, such as Matrigel, are made using live mice. As their exact composition is unknown and they are often inconsistent, these products can introduce variability into experiments, affecting results. Transitioning to animal-free versions of these products is therefore an important step toward more reliable and effective, human-specific research.
Information on other types of animal-derived products commonly used in research can be found on our Animal-Derived Products page.
Find out more about our current and completed animal-free research projects:
Aberdeen ARC: Professor Valerie Speirs
At our Aberdeen Animal Replacement Centre of Excellence, Professor Val Speirs and her team are replacing animal-derived products in models of human biology.
A slice of innovation: advancing research into diabetic kidney disease
Professor Mirela Delibegovic at the University of Aberdeen is using human precision-cut kidney slices to study diabetic kidney disease.
Improving tissue models for breast cancer research
Dr Hannah Harrison at the University of Manchester is replacing animal-derived products in a human breast cancer cell model.
Exeter ARC: Professor Lorna Harries
At our Animal Replacement Centre of Excellence (ARC) at the University of Exeter, Professor Lorna Harries and her team champion animal-free methods to study human diseases.
London ARC: Dr Adrian Biddle
At our London Animal Replacement Centre of Excellence (ARC) Dr Adrian Biddle is developing animal-free models to study cancer metastasis.
London ARC: Professor Mike Philpott
At our London Animal Replacement Centre of Excellence (ARC), Professor Mike Philpott and Dr Adrian Biddle are developing animal-free models to study cancer metastasis.
From plants to patients: growing tomorrow’s medicines today
Professor Julian Ma is using genetically modified plants to produce life-saving monoclonal antibody treatments for cancer, rabies, malaria and other diseases.Â
Replacing foetal calf serum (FCS) in breast cancer research
Dr Fiona Saunders is helping breast cancer researchers to go animal-free by testing ethical, reliable alternatives to foetal calf serum (FCS) for growing cells.
Predicting side effects to improve prostate cancer treatment
Dr Ethan Perkins at the University of Bradford is developing an advanced human cell model of prostate cancer to predict treatment side effects.
Transforming liver research with animal-free methods
Professor Ian Copple at the University of Liverpool is exploring ethical alternatives to foetal calf serum (FCS) for growing liver cells in the lab.
lifETIME CDT – Celia Ribes Balanza
lifETIME CDT student Celia Ribes Balanza is developing human tissue models to study leukemia, without the use of animals.
lifETIME CDT – Athena Mattheou
lifETIME CDT student Athena Mattheou aims to develop animal-free hydrogels suitable for skin healing applications.
